Business Trip
Un pódcast de Greg Kubin & Matias Serebrinsky - Jueves
59 Episodo
-
Holy poop! Mental health and the gut (part 2 with Bloom Science)
Publicado: 28/9/2023 -
Holy poop! Mental health and the gut (part 1 with Holobiome)
Publicado: 14/9/2023 -
Ketamine for OCD: Carolyn Rodriguez (Stanford pt 3)
Publicado: 24/8/2023 -
Are psychedelics effective under anesthesia?: Boris Heifets (Stanford pt 2)
Publicado: 17/8/2023 -
The Startup Landscape for Expanding Consciousness
Publicado: 9/8/2023 -
Stanford Psychedelic Overview: Robert Malenka (Stanford pt 1)
Publicado: 20/7/2023 -
Live from Psychedelic Science 2023
Publicado: 7/7/2023 -
What VCs Look for in Psychedelic Companies
Publicado: 9/6/2023 -
Developing Non-Hallucinogenic Psychedelics: Bryan Roth
Publicado: 15/5/2023 -
Behind the Scenes of PsyMed Ventures
Publicado: 14/4/2023 -
The 2023 Psychedelic Industry Landscape with Psychedelic Alpha
Publicado: 27/2/2023 -
The State of Psychedelics (Part 2): Dr. Rachel Yehuda and Zach Haigney (live recording at Soho House)
Publicado: 18/1/2023 -
The quest to improve MDMA
Publicado: 20/12/2022 -
Transcranial magnetic stimulation (TMS) paired with ketamine: inside a clinic offering a frontier treatment
Publicado: 29/11/2022 -
Perspectives from Christian Angermayer, investor and founder in psychedelics
Publicado: 27/10/2022 -
Soltara: an ethical and profitable ayahuasca retreat
Publicado: 14/9/2022 -
Microdosing (part 3): The path to FDA approval w/ MindMed and Diamond Therapeutics
Publicado: 16/8/2022 -
Microdosing (part 2): Placebo is a hell of a drug with Balázs Szigeti
Publicado: 10/8/2022 -
Microdosing (part 1): James Fadiman and the fundamentals of microdosing
Publicado: 3/8/2022 -
How the DEA and FDA will regulate psychedelic medicine
Publicado: 24/6/2022
Business Trip tells the story of businesses at the frontier of mental health and brain health. Each episode features founders, investors, and researchers in psychedelics, neurotechnology, metabolic psychiatry, digital therapeutics, and more.
